<DOC>
	<DOCNO>NCT00508027</DOCNO>
	<brief_summary>Recent clinical experimental data indicate statin effect beyond cholesterol lowering may beneficial sickle cell disease protect vascular endothelium . Statins show attenuate endothelial dysfunction anti-inflammatory , anti-oxidant anti-thrombotic property . This phase I/II dose-escalating trial design assess safety potential clinical efficacy oral simvastatin ( Zocor ) adolescents adults sickle cell disease ( SCD ) .</brief_summary>
	<brief_title>Simvastatin ( Zocor ) Therapy Sickle Cell Disease</brief_title>
	<detailed_description>Although statin use extensively cholesterol-lowering effect , recent clinical experimental data indicate statin regulate yet process , many play major role sickle cell disease ( SCD ) . Independent cholesterol-lowering effect , statin show prevent damage blood vessel several way , upregulation endothelial nitric oxide ( NO ) decrease inflammation . Numerous study document protective effect statin , together data show therapeutic role NO SCD , provide basis investigate potential clinical benefit simvastatin SCD . Data support safety tolerability simvastatin patient SCD need . For phase I/II dose-escalation study oral simvastatin SCD , propose follow specific aim : 1 . To obtain preliminary efficacy data effect oral simvastatin plasma biomarkers endothelial injury patient SCD , 2 . To assess safety tolerability oral simvastatin patient SCD .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Established diagnosis sickle cell disease ( HbSS , SC SÎ²thalassemia ) Age great equal thirteen year Weight great equal 35 kg Renal dysfunction ( Serum Creatinine &gt; 1.5 UNL ) Hepatic dysfunction ( ALT &gt; 2X UNL ) Pretreatment total cholesterol &lt; 100 mg/dL triglyceride &lt; 30 mg/dL Pretreatment baseline creatine kinase &gt; 1X UNL ( 215 U/L ) Pregnancy/lactation RBC transfusion last 30 day VasoOcclusive Event need hospitalization past 30 day Treatment statin drug within past 30 day Treatment drug know metabolic interaction statin drug ( e.g . cytochrome P450 3A4 metabolism ) , include ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , azithromycin , niacin ( nicotinic acid ) , digoxin , coumadin , sildenafil amiodarone within past 30 day Treatment ( past present ) amiodarone Musculoskeletal disorder associate elevated creatine kinase level Past present history substance abuse ( alcohol , cocaine , amphetamine , heroin , PCP ) Allergy statin</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>sickle cell disease</keyword>
	<keyword>simvastatin</keyword>
	<keyword>statin drug</keyword>
	<keyword>nitric oxide donor</keyword>
	<keyword>vascular injury</keyword>
</DOC>